(Q43168345)

English

The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects

scientific article published on 8 February 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1 reference

based on heuristic

inferred from title

author name string

M Liem-Moolenaar

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

R W M Zoethout

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

P de Boer

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

M Schmidt

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

M L de Kam

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

A F Cohen

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

K L Franson

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

J M A van Gerven

8

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

language of work or name

0 references

publication date

8 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

1671-1679

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Effects of scopolamine and D-cycloserine on non-spatial reference memory in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Delinquents and the Tapping Test

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Structure, function and regulation of glycine neurotransporters

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Visual motor co-ordination and dynamic visual acuity

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Modelling dementia: effects of scopolamine on memory and attention

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Qualitative analysis of scopolamine-induced amnesia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Biomarkers for the effects of benzodiazepines in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Biomarkers for the effects of antipsychotic drugs in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Memory and cognitive function in man: Does the cholinergic system have a specific role?

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Human memory and the cholinergic system. A relationship to aging?

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Scopolamine model of dementia: electroencephalogram findings and cognitive performance.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Studies on human memory: The interactions of diazepam, scopolamine, and physostigmine

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Early clinical testing of cognition enhancers: prediction of efficacy

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Effects of NMDA Modulation in Scopolamine Dementiaa

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

NMDA receptor pathways as drug targets

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Concurrent activation of hippocampal glycine and polyamine sites of the N-methyl-D-aspartate receptor synergistically reverses working memory deficits in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Reduced Stroop interference for opponent colors may be due to input factors: evidence from individual differences and a neural network simulation.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pharmacokinetics and pharmacodynamics in clinical use of scopolamine

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Cognition enhancers in age-related cognitive decline

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

D-cycloserine, a modulator of the N-methyl-D-aspartate receptor, improves spatial learning in rats treated with muscarinic antagonist.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Studies of interference in serial verbal reactions

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Estimation of pupil size by digital photography.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Effect of intrapulmonary tetrahydrocannabinol administration in humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106942

21 January 2018

Identifiers

10.1177/0269881109106942

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43168345&oldid=1982786068"